« previous next »
Pages: [1]

Author Topic: (MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients  (Read 106 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(MS Journal editorial) Emerging safety issues in alemtuzumab-treated MS patients
« on: August 02, 2019, 02:55:41 pm »

An editorial with cautions about Lemtrada--"Emerging safety issues in alemtuzumab-treated MS patients" in Multiple Sclerosis Journal (August 1, 2019):

https://journals.sagepub.com/doi/full/10.1177/1352458519851219
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
1 Replies
217 Views 		Last post April 06, 2016, 10:01:36 am
by agate
0 Replies
153 Views 		Last post September 16, 2016, 11:36:28 am
by agate
1 Replies
193 Views 		Last post December 23, 2016, 03:55:53 pm
by agate
0 Replies
77 Views 		Last post April 05, 2021, 03:17:30 pm
by agate
0 Replies
32 Views 		Last post May 08, 2021, 08:52:14 pm
by agate